Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.
Dalian Bio-Chem Co Ltd (603360) - Total Assets
Latest total assets as of September 2025: CN¥3.66 Billion CNY
Based on the latest financial reports, Dalian Bio-Chem Co Ltd (603360) holds total assets worth CN¥3.66 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dalian Bio-Chem Co Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Dalian Bio-Chem Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dalian Bio-Chem Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Dalian Bio-Chem Co Ltd's total assets of CN¥3.66 Billion consist of 69.0% current assets and 31.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 18.4% |
| Accounts Receivable | CN¥551.58 Million | 15.2% |
| Inventory | CN¥902.35 Million | 24.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥137.21 Million | 3.8% |
| Goodwill | CN¥230.53 Million | 6.3% |
Asset Composition Trend (2011–2024)
This chart illustrates how Dalian Bio-Chem Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dalian Bio-Chem Co Ltd's current assets represent 69.0% of total assets in 2024, an increase from 26.1% in 2011.
- Cash Position: Cash and equivalents constituted 18.4% of total assets in 2024, up from 8.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 19.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 24.8% of total assets.
Dalian Bio-Chem Co Ltd Competitors by Total Assets
Key competitors of Dalian Bio-Chem Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
Dalian Bio-Chem Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Dalian Bio-Chem Co Ltd generates 0.36x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Dalian Bio-Chem Co Ltd generates $9.49 in net profit.
Dalian Bio-Chem Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.96 | 5.07 | 1.54 |
| Quick Ratio | 1.55 | 4.50 | 1.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.60 Billion | CN¥ 1.06 Billion | CN¥ 215.47 Million |
Dalian Bio-Chem Co Ltd - Advanced Valuation Insights
This section examines the relationship between Dalian Bio-Chem Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.79 |
| Latest Market Cap to Assets Ratio | 0.27 |
| Asset Growth Rate (YoY) | 87.5% |
| Total Assets | CN¥3.64 Billion |
| Market Capitalization | $978.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dalian Bio-Chem Co Ltd's assets below their book value (0.27 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Dalian Bio-Chem Co Ltd's assets grew by 87.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dalian Bio-Chem Co Ltd (2011–2024)
The table below shows the annual total assets of Dalian Bio-Chem Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.64 Billion | +87.45% |
| 2023-12-31 | CN¥1.94 Billion | +10.68% |
| 2022-12-31 | CN¥1.75 Billion | +5.01% |
| 2021-12-31 | CN¥1.67 Billion | +16.86% |
| 2020-12-31 | CN¥1.43 Billion | +20.21% |
| 2019-12-31 | CN¥1.19 Billion | +32.53% |
| 2018-12-31 | CN¥897.38 Million | +15.15% |
| 2017-12-31 | CN¥779.33 Million | +24.42% |
| 2016-12-31 | CN¥626.37 Million | +14.25% |
| 2015-12-31 | CN¥548.25 Million | -2.96% |
| 2014-12-31 | CN¥564.99 Million | +3.33% |
| 2013-12-31 | CN¥546.78 Million | +10.80% |
| 2012-12-31 | CN¥493.50 Million | +7.57% |
| 2011-12-31 | CN¥458.76 Million | -- |